MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 94 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q4 2013. The put-call ratio across all filers is 0.34 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $1,631,000 | -54.7% | 1,317,513 | +12.7% | 0.00% | -66.7% |
| Q1 2017 | $3,598,000 | -36.0% | 1,168,957 | -15.2% | 0.00% | -40.0% |
| Q4 2016 | $5,622,000 | -39.8% | 1,378,806 | -6.3% | 0.01% | -28.6% |
| Q3 2016 | $9,338,000 | +12.3% | 1,470,909 | -4.7% | 0.01% | +16.7% |
| Q2 2016 | $8,317,000 | -45.4% | 1,543,402 | -15.2% | 0.01% | -45.5% |
| Q1 2016 | $15,228,000 | +9.9% | 1,819,617 | +3.7% | 0.01% | +10.0% |
| Q4 2015 | $13,861,000 | -7.9% | 1,754,706 | -0.8% | 0.01% | -16.7% |
| Q3 2015 | $15,054,000 | -32.8% | 1,769,193 | -2.4% | 0.01% | -14.3% |
| Q2 2015 | $22,409,000 | +5.5% | 1,812,498 | +1.3% | 0.01% | +7.7% |
| Q1 2015 | $21,246,000 | -3.0% | 1,788,554 | -7.7% | 0.01% | -7.1% |
| Q4 2014 | $21,904,000 | +32.0% | 1,938,584 | +2.6% | 0.01% | +40.0% |
| Q3 2014 | $16,595,000 | -6.5% | 1,890,244 | -22.4% | 0.01% | -16.7% |
| Q2 2014 | $17,756,000 | +355.4% | 2,436,028 | +214.9% | 0.01% | +300.0% |
| Q1 2014 | $3,899,000 | +4.0% | 773,622 | +10.0% | 0.00% | 0.0% |
| Q4 2013 | $3,750,000 | +26.6% | 703,585 | -10.1% | 0.00% | +50.0% |
| Q3 2013 | $2,963,000 | – | 782,330 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 5,000,000 | $20,400,000 | 4.19% |
| Consonance Capital Management LP | 9,067,998 | $36,997,000 | 4.06% |
| Lagoda Investment Management, L.P. | 1,522,529 | $6,212,000 | 2.13% |
| INDUS CAPITAL PARTNERS, LLC | 1,050,000 | $4,284,000 | 0.56% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 9,072,877 | $37,017,000 | 0.32% |
| GARRISON BRADFORD & ASSOCIATES INC | 77,700 | $317,000 | 0.29% |
| Cannell & Co. | 1,572,978 | $6,418,000 | 0.23% |
| Virtus ETF Advisers LLC | 179,625 | $733,000 | 0.22% |
| LeJeune Puetz Investment Counsel LLC | 3,976 | $161,000 | 0.12% |
| STONERIDGE INVESTMENT PARTNERS LLC | 221,838 | $905,000 | 0.12% |